Inari Medical Future Growth

Future criteria checks 4/6

Inari Medical is forecast to grow earnings and revenue by 73.9% and 15.6% per annum respectively. EPS is expected to grow by 74.8% per annum. Return on equity is forecast to be 5.1% in 3 years.

Key information

73.9%

Earnings growth rate

74.8%

EPS growth rate

Medical Equipment earnings growth16.1%
Revenue growth rate15.6%
Future return on equity5.1%
Analyst coverage

Good

Last updated01 May 2024

Recent future growth updates

Recent updates

Is Inari Medical, Inc. (NASDAQ:NARI) Trading At A 29% Discount?

May 02
Is Inari Medical, Inc. (NASDAQ:NARI) Trading At A 29% Discount?

Inari Medical: Buy On Growing TAM

Mar 27

Why We're Not Concerned Yet About Inari Medical, Inc.'s (NASDAQ:NARI) 25% Share Price Plunge

Mar 08
Why We're Not Concerned Yet About Inari Medical, Inc.'s (NASDAQ:NARI) 25% Share Price Plunge

Is Now The Time To Look At Buying Inari Medical, Inc. (NASDAQ:NARI)?

Dec 14
Is Now The Time To Look At Buying Inari Medical, Inc. (NASDAQ:NARI)?

A Look At The Fair Value Of Inari Medical, Inc. (NASDAQ:NARI)

Oct 23
A Look At The Fair Value Of Inari Medical, Inc. (NASDAQ:NARI)

Inari Medical (NASDAQ:NARI) Is In A Strong Position To Grow Its Business

Sep 18
Inari Medical (NASDAQ:NARI) Is In A Strong Position To Grow Its Business

Is Inari Medical, Inc. (NASDAQ:NARI) Potentially Undervalued?

Aug 14
Is Inari Medical, Inc. (NASDAQ:NARI) Potentially Undervalued?

Inari Medical, Inc. (NASDAQ:NARI) Shares Could Be 23% Above Their Intrinsic Value Estimate

Jul 25
Inari Medical, Inc. (NASDAQ:NARI) Shares Could Be 23% Above Their Intrinsic Value Estimate

We Think Inari Medical (NASDAQ:NARI) Can Afford To Drive Business Growth

Jun 18
We Think Inari Medical (NASDAQ:NARI) Can Afford To Drive Business Growth

Inari Medical, Inc.'s (NASDAQ:NARI) Price In Tune With Revenues

Apr 17
Inari Medical, Inc.'s (NASDAQ:NARI) Price In Tune With Revenues

Is Inari Medical, Inc. (NASDAQ:NARI) Potentially Undervalued?

Dec 07
Is Inari Medical, Inc. (NASDAQ:NARI) Potentially Undervalued?

Study assessing Inari Medical's blood clot removal system shows low rate of adverse events

Sep 19

Inari Medical: Growth Set To Reaccelerate In The Back Half Of The Year

Sep 07

Inari Medical stock falls as Q2 sees net loss; COO to helm company next year

Aug 03

Inari Medical: Fundamentals Soft, Technicals Supportive Of Near-Term Upside Capture

Jul 22

Earnings and Revenue Growth Forecasts

NasdaqGS:NARI - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20268252941517
12/31/20257058152410
12/31/2024599-50-5-810
3/31/2024521-241926N/A
12/31/2023494-23036N/A
9/30/2023469-32935N/A
6/30/2023439-1606N/A
3/31/2023413-28-15-7N/A
12/31/2022383-29-24-14N/A
9/30/2022359-22-21-10N/A
6/30/2022336-15-16-3N/A
3/31/2022306-1-88N/A
12/31/2021277101225N/A
9/30/202124216-49N/A
6/30/2021208251020N/A
3/31/202117017511N/A
12/31/202014014-42N/A
9/30/20201117-13N/A
6/30/2020861-7-3N/A
3/31/2020714-7-4N/A
12/31/201951-1-8-5N/A
12/31/20187-10-12-11N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: NARI is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.4%).

Earnings vs Market: NARI is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: NARI is expected to become profitable in the next 3 years.

Revenue vs Market: NARI's revenue (15.6% per year) is forecast to grow faster than the US market (8.3% per year).

High Growth Revenue: NARI's revenue (15.6% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: NARI's Return on Equity is forecast to be low in 3 years time (5.1%).


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.